Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Clinical trial NCT06800950 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06800950
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human Influenza, Human Prevention Influenza a Influenza B Influenza Viral Infections

Start date: 2025-02-08
Primary completion: 2025-07-15
Enrollment: 4400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.